Skip to main content
NVDA-0.18%AAPL-0.21%GOOGL+0.59%MSFT-0.44%AMZN-0.15%TSM-1.68%SPCX+0.43%AVGO-0.97%META-0.47%TSLA-0.02%SKHY-5.20%MU-0.52%BRK-B+0.06%LLY-0.10%JPM-0.32%WMT-0.09%AMD-3.36%V-0.05%XOM+0.61%ASMLa-1.66%JNJ-0.27%INTC-5.57%0700.HK+1.01%MA-0.38%1398.HK-0.23%ABBV+1.62%BAC-0.18%ORCL-5.23%CVX-0.50%CSCO-1.82%COST-0.02%KO+0.32%LRCX-5.65%CAT-1.29%AP2d-1.55%AMAT-3.17%0005.HK-1.48%HSBA.L-1.30%UNH-1.22%PG+0.25%DELL-5.35%GE-0.39%MS-1.22%1816.HK-29.18%3988.HK+0.46%0857.HK+0.59%NFLX-0.03%HD-1.53%0939.HK+0.23%GS-0.88%NZDJPY-2.05%AUDJPY-1.79%CHFJPY-1.62%GBPJPY-1.28%EURJPY-1.25%CADJPY-1.22%USDJPY-1.20%NZDUSD-0.88%NZDCAD-0.85%EURNZD+0.83%GBPNZD+0.77%USDTHB+0.74%AUDUSD-0.60%AUDCAD-0.60%NZDSGD+0.56%EURAUD+0.55%NZDMXN+0.50%GBPAUD+0.50%NZDCHF-0.47%USDCHF+0.43%GBPTRY+0.41%CADCHF+0.38%EURCHF+0.36%USDTRY+0.33%GBPCHF+0.33%GBPHKD+0.32%GBPMXN-0.28%AUDNZD+0.28%AUDCHF-0.17%GBPZAR-0.16%USDILS+0.16%EURZAR-0.15%NOKJPY-0.12%AUDNOK+0.12%USDZAR-0.11%EURCNH-0.10%PLNJPY-0.09%GBPUSD-0.09%GBPCAD-0.07%CHFNOK+0.07%AUDDKK+0.07%USDNOK+0.07%EURUSD-0.06%GBPSGD-0.06%USDPLN+0.05%EURNOK+0.05%USDMXN-0.05%EURGBP+0.04%EURSGD-0.04%SGDJPY-0.04%AUDSGD+0.04%USDSEK+0.04%USDCOP-0.04%CHFSEK+0.04%USDCNH+0.04%EURHKD-0.04%EURCAD-0.03%USDCAD+0.03%USDDKK+0.03%EURCZK-0.02%USDHKD+0.01%EURSEK+0.01%CHFSGD-0.01%EURPLN+0.01%USDSGD-0.01%EURDKK-0.01%USOIL-1.60%UKOIL-1.29%W1-1.06%COTTON-0.99%C1-0.98%S1-0.90%XNGUSD-0.24%GAUUSD+0.22%XAUUSD+0.22%HG1+0.20%XPTUSD+0.20%GAGUSD-0.17%BTCUSD-1.49%ETHUSD-0.30%USDTUSD-0.02%XRPUSD-3.40%SOLUSD-1.72%TRXUSDT+0.03%ZECUSDT-12.77%DOGEUSD-2.53%XMRUSDT+1.13%LINKUSD-2.34%XLMUSD-2.52%BCHUSDT-9.43%LTCUSD-0.48%UNIUSD-0.53%TONUSD+24.88%HBARUSDT-1.81%SUIUSD-3.96%TAOUSDT-6.88%DOTUSDT+0.94%AAVEUSD-2.44%ICPUSDT+0.86%ONDOUSDT-2.87%WLDUSDT-3.15%ATOMUSDT-4.27%ARBUSDT-1.30%JUPUSDT+1.75%INJUSDT-1.72%STXUSDT-6.35%FETUSDT-0.62%TIAUSDT-1.92%PYTHUSDT-0.75%SEIUSDT-6.02%IMXUSDT-4.65%WIFUSDT-5.38%GRTUSDT-5.15%OPUSDT-3.00%POLUSDT-4.55%IOTAUSDT-3.25%AXSUSDT-1.39%FARTCOINUSDT-2.67%EOSUSDT-2.91%DYDXUSDT-0.65%ORDIUSDT-0.03%GALAUSDT-4.21%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-0.18%AAPL-0.21%GOOGL+0.59%MSFT-0.44%AMZN-0.15%TSM-1.68%SPCX+0.43%AVGO-0.97%META-0.47%TSLA-0.02%SKHY-5.20%MU-0.52%BRK-B+0.06%LLY-0.10%JPM-0.32%WMT-0.09%AMD-3.36%V-0.05%XOM+0.61%ASMLa-1.66%JNJ-0.27%INTC-5.57%0700.HK+1.01%MA-0.38%1398.HK-0.23%ABBV+1.62%BAC-0.18%ORCL-5.23%CVX-0.50%CSCO-1.82%COST-0.02%KO+0.32%LRCX-5.65%CAT-1.29%AP2d-1.55%AMAT-3.17%0005.HK-1.48%HSBA.L-1.30%UNH-1.22%PG+0.25%DELL-5.35%GE-0.39%MS-1.22%1816.HK-29.18%3988.HK+0.46%0857.HK+0.59%NFLX-0.03%HD-1.53%0939.HK+0.23%GS-0.88%NZDJPY-2.05%AUDJPY-1.79%CHFJPY-1.62%GBPJPY-1.28%EURJPY-1.25%CADJPY-1.22%USDJPY-1.20%NZDUSD-0.88%NZDCAD-0.85%EURNZD+0.83%GBPNZD+0.77%USDTHB+0.74%AUDUSD-0.60%AUDCAD-0.60%NZDSGD+0.56%EURAUD+0.55%NZDMXN+0.50%GBPAUD+0.50%NZDCHF-0.47%USDCHF+0.43%GBPTRY+0.41%CADCHF+0.38%EURCHF+0.36%USDTRY+0.33%GBPCHF+0.33%GBPHKD+0.32%GBPMXN-0.28%AUDNZD+0.28%AUDCHF-0.17%GBPZAR-0.16%USDILS+0.16%EURZAR-0.15%NOKJPY-0.12%AUDNOK+0.12%USDZAR-0.11%EURCNH-0.10%PLNJPY-0.09%GBPUSD-0.09%GBPCAD-0.07%CHFNOK+0.07%AUDDKK+0.07%USDNOK+0.07%EURUSD-0.06%GBPSGD-0.06%USDPLN+0.05%EURNOK+0.05%USDMXN-0.05%EURGBP+0.04%EURSGD-0.04%SGDJPY-0.04%AUDSGD+0.04%USDSEK+0.04%USDCOP-0.04%CHFSEK+0.04%USDCNH+0.04%EURHKD-0.04%EURCAD-0.03%USDCAD+0.03%USDDKK+0.03%EURCZK-0.02%USDHKD+0.01%EURSEK+0.01%CHFSGD-0.01%EURPLN+0.01%USDSGD-0.01%EURDKK-0.01%USOIL-1.60%UKOIL-1.29%W1-1.06%COTTON-0.99%C1-0.98%S1-0.90%XNGUSD-0.24%GAUUSD+0.22%XAUUSD+0.22%HG1+0.20%XPTUSD+0.20%GAGUSD-0.17%BTCUSD-1.49%ETHUSD-0.30%USDTUSD-0.02%XRPUSD-3.40%SOLUSD-1.72%TRXUSDT+0.03%ZECUSDT-12.77%DOGEUSD-2.53%XMRUSDT+1.13%LINKUSD-2.34%XLMUSD-2.52%BCHUSDT-9.43%LTCUSD-0.48%UNIUSD-0.53%TONUSD+24.88%HBARUSDT-1.81%SUIUSD-3.96%TAOUSDT-6.88%DOTUSDT+0.94%AAVEUSD-2.44%ICPUSDT+0.86%ONDOUSDT-2.87%WLDUSDT-3.15%ATOMUSDT-4.27%ARBUSDT-1.30%JUPUSDT+1.75%INJUSDT-1.72%STXUSDT-6.35%FETUSDT-0.62%TIAUSDT-1.92%PYTHUSDT-0.75%SEIUSDT-6.02%IMXUSDT-4.65%WIFUSDT-5.38%GRTUSDT-5.15%OPUSDT-3.00%POLUSDT-4.55%IOTAUSDT-3.25%AXSUSDT-1.39%FARTCOINUSDT-2.67%EOSUSDT-2.91%DYDXUSDT-0.65%ORDIUSDT-0.03%GALAUSDT-4.21%NOTUSDT-2.97%RONINUSDT-2.64%
GL

Glaukos Corporation (GKOS)

NYSE • Healthcare

$170.38
-$9.4 (-5.2%)
Market closed

Last close at September 10, 2026 at 20:00 UTC

Open$176.71
Day Range$169.61 - $179.96
Avg. Volume (3M)651.8K
Market Cap$10B
52 Week Range
$73.16$191.62
Next EarningsIn 54 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$185.6M100%
Gross Profitminus cost of goods$151.5M82%

In plain terms: out of every $100 in revenue, Glaukos Corporation currently loses $10.

Fundamentals & Financials

Revenue (TTM)
$612.8M
Net Income (TTM)
-$188M
EPS (TTM)
-$3.25
ROA (TTM)
-20.43%
Current Ratio
5.04

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-27.3%Q1 2026-$0.28
+40.0%Q2 2026-$0.18
+33.5%Q3 2026-$0.14
Next

Nov 4

in 54 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +33.5%

Glaukos beat expectations on both revenue and adjusted EPS in the second fiscal quarter of 2026, reported July 29, as revenue rose about 50% to about $185.6 million from about $124.1 million a year ago and beat the $150.9 million consensus by about 23%, while adjusted EPS of -$0.14 topped the -$0.21 estimate by about 34%. Gross margin came in near 82%, while operating margin was near -9% as operating income was negative about $17.3 million and net income was negative about $18.4 million, up about 7% from negative $19.7 million a year ago. Operating cash flow was about $14.8 million, and next-period consensus calls for EPS of -$0.16 on revenue of $156.0 million.

View full earnings history

About Glaukos Corporation

Glaukos Corporation trades on the NYSE under GKOS and develops ophthalmic medical devices, centered on minimally invasive glaucoma products. Its FY2025 revenue was $507.4 million. The company sells iStent, iStent inject, and iStent inject W for use in cataract surgery and in treating mild-to-moderate open-angle glaucoma.

Name
Glaukos Corporation
CEO
Thomas William Burns
Website
www.glaukos.com
Industry
Healthcare
Year Founded
1998
Employees
1,094

Today's Snapshot

AI-generated

The day ended with GKOS 5.2% lower at 170.38, in line with a weaker sector. Volume was about half as much again as its usual level.

Trading Volume

Above 10d avg 666.6K

1M

vs S&P 500 Today

Strong Underperformance

-4.66%

Updated: September 10, 2026 at 20:23 UTC

Technical Indicators

3 Buy3 Neutral2 Sell
GKOS is technically neutral as short-term averages sit above the current price while the mid- and long-term moving averages remain supportive, leaving a split between near-term weakness and longer-term strength. Momentum indicators are subdued and ADX confirms a lack of a strong trend, while Bollinger positioning and stochastic readings suggest the shares are not deeply oversold. Volume metrics are soft and the pivot lies overhead, so price action lacks conviction despite a constructive broader trend. Technical takeaway: Neutral.
All signals
  • EMA (5 indicators)$133.64 - $178.81
    Buy
  • RSI (14)42.84
    Neutral
  • Stochastic %K (14, 3, 3)35.78
    Neutral
  • MACD Level (12, 26)2.11
    Neutral

Peers & Related Assets

ARWRArrowhead Pharmaceuticals, Inc.
$82.76+0.2%
OSCROscar Health, Inc.
$32.58+2.6%
BRKRBruker Corporation
$53.56-1.6%
ALKSAlkermes plc
$46.11+1.6%
TFXTeleflex Incorporated
$132-2.7%
MMSIMerit Medical Systems, Inc.
$86.47-0.8%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.